pegylated liposomal doxorubicin - Generic mfg.
ATRC-101 - Atreca
Keytruda (pembrolizumab) - Merck (MSD)
https://www.globenewswire.com/news-release/2021/08/11/2279186/0/en/Atreca-Reports-Second-Quarter-2021-Financial-Results-and-Recent-Corporate-Developments.html
 
Aug 11, 2021
 
Prev Next